TT Capital Partners (TTCP), a source of capital and expertise for growth-stage healthcare technology and services companies, has promoted Adam Letson and Donnacha O’Sullivan to the role of principal and the additions of July Hugen as head of investor relations and Ryan Schultz as vice president.
These personnel changes deepen TTCP’s healthcare investing team during a period of strong business momentum.
“At TTCP we strive to be value-add investors, requiring a team of professionals who are students of healthcare and bring a level of expertise and inquisitiveness to everything we do,” says Conor Green, Partner. “Both Adam and Donnacha embodied these traits throughout 2020 by leading our efforts on new investments, strategic portfolio company combinations and successful exits.”
The addition of Hugen as head of investor relations and Schultz as vice president demonstrate TTCP’s continued focus on industry relationships. Hugen joined the firm in March 2021 after prior experience at Argentem Creek Partners and Pine River Capital Management. Schultz joined TTCP in July 2021 after roles at Piper Sandler, Cresset and Sterling Partners.
“Relationships are key to advancing the healthcare industry and strengthening the service we provide our institutional and strategic investors, as well as the innovators and companies we invest in,” says Ryan Engle, Partner. “Both July and Ryan bring deep professional experience to the firm that will allow us to better serve our key stakeholders, while ensuring TTCP’s role as a value-add investor.”
TTCP is the capital behind many successful healthcare technology and services companies. Over the past year, TTCP’s investing strategy has contributed to successful outcomes, including early investments in Remedy (now the publicly-traded Signify Health), investments in Revel (recently merged with NovuHealth to form Icario) and the recent sale of Updox to Evercommerce.
